- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TYK Medicines Inc (2410)
TYK Medicines Inc stock price live, this page displays HK 2410 stock exchange data. View the 2410 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TYK Medicines Inc real time stock price chart below.
What Is the TYK Medicines Inc Stock Price Today?
The TYK Medicines Inc stock price today is 12.76.
What Is the Stock Symbol for TYK Medicines Inc?
The stock symbol for TYK Medicines Inc is "2410."
What Stock Exchange Does TYK Medicines Inc Trade On?
TYK Medicines Inc is listed and trades on the Hong Kong stock exchange.
Is TYK Medicines Inc a Good Stock to Buy?
Determining whether TYK Medicines Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2410 quote. (ISIN: CNE100006L34)
What Is the TYK Medicines Inc Stock Price Today?
The TYK Medicines Inc stock price today is 12.76.
What Is the Stock Symbol for TYK Medicines Inc?
The stock symbol for TYK Medicines Inc is "2410."
What Stock Exchange Does TYK Medicines Inc Trade On?
TYK Medicines Inc is listed and trades on the Hong Kong stock exchange.
Is TYK Medicines Inc a Good Stock to Buy?
Determining whether TYK Medicines Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2410 quote. (ISIN: CNE100006L34)
Hong Kong
Currency in HKD
12.76
-0.04(-0.31%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.71
12.98
52 wk Range
12.10
46.10
2410 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.7112.98
52 wk Range
12.1046.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2410 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
24.41
Upside
+91.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
TYK Medicines Inc Company Profile
TYK Medicines, Inc., a clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products. Its lead product candidate is TY-9591, a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor for the treatment of brain metastases from non-small cell lung cancer (NSCLC) with EGFR mutations, and in locally advanced or metastatic NSCLC with EGFR L858R mutation. The company also develops TY-302, an oral cyclin-dependent kinase (CDK) 4/6 inhibitor to treat solid tumors, including breast cancer and prostate cancer; TY-2136b, an oral ROS proto-oncogene 1/neurotrophic tyrosine receptor kinase inhibitor for the treatment of solid tumors; TY-2699a, a selective CDK7 inhibitor for the treatment of advanced/metastatic solid tumors; and TY-0540, a selective CDK2/4/6 inhibitor to treat advanced/metastatic solid tumors. In addition, it develops TY-4028, an oral exon 20 insertion-TKI targeting locally advanced or metastatic NSCLC with EGFR exon 20 or HER2 exon 20 insertions; TY-1091, a potent and selective rearranged during transfection proto-oncogene (RET) inhibitor for the treatment of advanced NSCLC with RET gene fusion, advanced medullary thyroid cancer with RET gene mutation, and other advanced solid tumors with RET gene alterations; TY-1054, an oral yes associated protein-transcriptional enhanced associate domain inhibitor for cancer treatment; TY-1210, a selective CDK2 inhibitor to treat solid tumors; TY-0609, a selective CDK4 inhibitor for the treatment of cancer; and TY-3200, an EGFR degrader. The company was incorporated in 2017 and is headquartered in Huzhou, China.
Compare 2410 to Peers and Sector
Metrics to compare | 2410 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2410PeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.3x | −31.5x | −0.5x | |
PEG Ratio | −0.34 | −0.37 | 0.00 | |
Price/Book | 12.0x | 6.0x | 2.6x | |
Price / LTM Sales | 40,066.9x | 20.4x | 3.3x | |
Upside (Analyst Target) | 91.4% | 56.4% | 46.0% | |
Fair Value Upside | Unlock | −13.4% | 5.4% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 24.41
(+91.29% Upside)
Earnings
Latest Release
Sep 19, 2025
EPS / Forecast
-0.30 / --
Revenue / Forecast
-- / --
FAQ
What Is the TYK Medicines (2410) Stock Price Today?
The TYK Medicines stock price today is 12.76
What Stock Exchange Does TYK Medicines Trade On?
TYK Medicines is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for TYK Medicines?
The stock symbol for TYK Medicines is "2410."
What Is the TYK Medicines Market Cap?
As of today, TYK Medicines market cap is 4.85B.
What Is TYK Medicines's Earnings Per Share (TTM)?
The TYK Medicines EPS (TTM) is -0.77.
From a Technical Analysis Perspective, Is 2410 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has TYK Medicines Stock Split?
TYK Medicines has split 0 times.
How Many Employees Does TYK Medicines Have?
TYK Medicines has 163 employees.
What is the current trading status of TYK Medicines (2410)?
As of Feb 18, 2026, TYK Medicines (2410) is trading at a price of 12.76, with a previous close of 12.80. The stock has fluctuated within a day range of 12.71 to 12.98, while its 52-week range spans from 12.10 to 46.10.
What Is TYK Medicines (2410) Price Target According to Analysts?
The average 12-month price target for TYK Medicines is HKD24.41, with a high estimate of HKD24.40837104 and a low estimate of HKD24.40837104. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +91.29% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.